Skip to main content
Log in

Erstes Opioid gegen Restless-legs-Syndrom zugelassen

  • Pharmaforum
  • Published:
DNP - Der Neurologe und Psychiater Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  • Satellitensymposium „Bestehende & neue Aspekte zum Einsatz von Opioiden in der Neurologie“, Neurowoche München, 16.9.2014; Veranstalter: Mundipharma

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fessler, B. Erstes Opioid gegen Restless-legs-Syndrom zugelassen. DNP 15, 88 (2014). https://doi.org/10.1007/s15202-014-0994-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15202-014-0994-4

Navigation